Learn, Analyse & Invest
only with
only with
+91
Download Orca
Aarey Drugs & Pharmaceuticals Ltd.
Aarey Drugs & Pharma
₹ 0.00
0.00 (0.00)%
NSE
BSE
Trading
Small-cap - With a market cap of ₹1.96 Cr.
| EX-Date | Purpose |
|---|---|
| 04 06 2021 | Inter alia, to consider and approve the following business:- 1. To review the expansion of manufacturing facilities of the Company, 2. To review new tie up to add product ine To review current business & raising funds from Bank 3. To consider the issue of equity shares/ and or warrants on preferential basis to the Promoters/Non Promoters of the Company. |
| 08 06 2021 | (Revised) The Board of Directors of the Company scheduled on 04/06/2021 is revised and will now be held on 08/06/2021, Inter alia, to consider and approve the following business:- 1. To review the expansion of manufacturing facilities of the Company, 2. To review new tie up to add product ine To review current business & raising funds from Bank 3. To consider the issue of equity shares/ and or warrants on preferential basis to the Promoters/Non Promoters of the Company. |
| 16 06 2021 | Preferential Issue of shares |
| 29 06 2021 | Audited Results |
| 10 08 2021 | Quarterly Results |
| 12 11 2021 | Quarterly Results |
| 25 11 2021 | Preferential Issue of shares |
| 08 02 2022 | Quarterly Results |
| 30 05 2022 | Audited Results |
| 13 08 2022 | Quarterly Results |
| 14 11 2022 | Quarterly Results |
| 08 02 2023 | Quarterly Results |
| 29 05 2023 | Audited Results |
| 20 06 2023 | Preferential Issue of shares |
| 21 06 2023 | Preferential Issue of shares & Increase in Authorised Capital |
| 31 07 2023 | Preferential Issue of shares |
| 10 08 2023 | Increase in Authorised Capital & Issue Of Warrants & Preferential Issue of shares |
| 14 08 2023 | Quarterly Results |
| 11 11 2023 | Quarterly Results |
| 14 02 2024 | Quarterly Results |
| 27 03 2024 | Inter alia, to consider the allotment of Equity Shares and Warrants |
| 01 10 2024 | Inter alia, to consider and approve the allotment of Equity Shares/Warrrantspursuant to Preferential Issue of Equity Shares/Warrrants. |
| 14 11 2024 | Quarterly Results |
| 29 11 2024 | Preferential Issue of shares & Issue Of Warrants Inter alia: a) To consider a proposal for issuance of equity shares by way of a preferential allotment, in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, as amended, subject to such regulatory / statutory approvals as may be required. b) To consider the matter regarding increase in Authorized Share Capital, if required / needed. c) Any other matter with consent of the Chairman |
| 04 12 2024 | Issue Of Warrants & Increase in Authorised Capital Inter alia: a) To consider a proposal for issuance of equity shares by way of a preferential allotment, in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, as amended, subject to such regulatory / statutory approvals as may be required. b) To consider the matter regarding increase in Authorized Share Capital, if required / needed. c) Any other matter with consent of the Chairman. |
| 14 02 2025 | Quarterly Results |
| 30 05 2025 | Audited Results |
| 13 08 2025 | Quarterly Results |
| 13 11 2025 | Quarterly Results |
| 11 02 2026 | Quarterly Results |
News
No News data available
